Humana Statistics
Total Valuation
Humana has a market cap or net worth of $30.97 billion. The enterprise value is $42.63 billion.
Important Dates
The last earnings date was Tuesday, February 11, 2025, before market open.
| Earnings Date | Feb 11, 2025 |
| Ex-Dividend Date | Dec 31, 2024 |
Share Statistics
Humana has 120.64 million shares outstanding. The number of shares has decreased by -2.87% in one year.
| Current Share Class | 120.64M |
| Shares Outstanding | 120.64M |
| Shares Change (YoY) | -2.87% |
| Shares Change (QoQ) | -0.26% |
| Owned by Insiders (%) | 0.18% |
| Owned by Institutions (%) | 97.85% |
| Float | 120.28M |
Valuation Ratios
The trailing PE ratio is 25.90 and the forward PE ratio is 15.75. Humana's PEG ratio is 10.21.
| PE Ratio | 25.90 |
| Forward PE | 15.75 |
| PS Ratio | 0.28 |
| Forward PS | 0.26 |
| PB Ratio | 2.00 |
| P/TBV Ratio | 4.85 |
| P/FCF Ratio | 13.69 |
| P/OCF Ratio | 11.04 |
| PEG Ratio | 10.21 |
Financial Ratio HistoryEnterprise Valuation
The stock's EV/EBITDA ratio is 10.63, with an EV/FCF ratio of 17.83.
| EV / Earnings | 35.32 |
| EV / Sales | 0.36 |
| EV / EBITDA | 10.63 |
| EV / EBIT | 14.01 |
| EV / FCF | 17.83 |
Financial Position
The company has a current ratio of 1.76, with a Debt / Equity ratio of 0.74.
| Current Ratio | 1.76 |
| Quick Ratio | 1.37 |
| Debt / Equity | 0.74 |
| Debt / EBITDA | 3.02 |
| Debt / FCF | 5.07 |
| Interest Coverage | 4.61 |
Financial Efficiency
Return on equity (ROE) is 7.41% and return on invested capital (ROIC) is 6.62%.
| Return on Equity (ROE) | 7.41% |
| Return on Assets (ROA) | 4.07% |
| Return on Invested Capital (ROIC) | 6.62% |
| Return on Capital Employed (ROCE) | 10.30% |
| Revenue Per Employee | $1.74M |
| Profits Per Employee | $17,855 |
| Employee Count | 65,680 |
| Asset Turnover | 2.52 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, Humana has paid $413.00 million in taxes.
| Income Tax | 413.00M |
| Effective Tax Rate | 25.38% |
Stock Price Statistics
The stock price has decreased by -26.06% in the last 52 weeks. The beta is 0.56, so Humana's price volatility has been lower than the market average.
| Beta (5Y) | 0.56 |
| 52-Week Price Change | -26.06% |
| 50-Day Moving Average | 271.60 |
| 200-Day Moving Average | 313.81 |
| Relative Strength Index (RSI) | 48.58 |
| Average Volume (20 Days) | 1,903,850 |
Short Selling Information
The latest short interest is 4.58 million, so 3.80% of the outstanding shares have been sold short.
| Short Interest | 4.58M |
| Short Previous Month | 5.58M |
| Short % of Shares Out | 3.80% |
| Short % of Float | 3.81% |
| Short Ratio (days to cover) | 3.08 |
Income Statement
In the last 12 months, Humana had revenue of $117.76 billion and earned $1.21 billion in profits. Earnings per share was $9.98.
| Revenue | 117.76B |
| Gross Profit | 17.10B |
| Operating Income | 3.04B |
| Pretax Income | 2.37B |
| Net Income | 1.21B |
| EBITDA | 4.01B |
| EBIT | 3.04B |
| Earnings Per Share (EPS) | $9.98 |
Full Income StatementBalance Sheet
The company has $20.44 billion in cash and $12.12 billion in debt, giving a net cash position of -$9.90 billion or -$82.09 per share.
| Cash & Cash Equivalents | 20.44B |
| Total Debt | 12.12B |
| Net Cash | -9.90B |
| Net Cash Per Share | -$82.09 |
| Equity (Book Value) | 16.45B |
| Book Value Per Share | 135.73 |
| Working Capital | 12.88B |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was $2.97 billion and capital expenditures -$575.00 million, giving a free cash flow of $2.39 billion.
| Operating Cash Flow | 2.97B |
| Capital Expenditures | -575.00M |
| Free Cash Flow | 2.39B |
| FCF Per Share | $19.82 |
Full Cash Flow StatementMargins
Gross margin is 14.52%, with operating and profit margins of 2.58% and 1.02%.
| Gross Margin | 14.52% |
| Operating Margin | 2.58% |
| Pretax Margin | 1.38% |
| Profit Margin | 1.02% |
| EBITDA Margin | 3.41% |
| EBIT Margin | 2.58% |
| FCF Margin | 2.03% |
Dividends & Yields
This stock pays an annual dividend of $3.54, which amounts to a dividend yield of 1.37%.
| Dividend Per Share | $3.54 |
| Dividend Yield | 1.37% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | 35.47% |
| Buyback Yield | 2.87% |
| Shareholder Yield | 4.18% |
| Earnings Yield | 3.69% |
| FCF Yield | 7.31% |
Dividend DetailsAnalyst Forecast
The average price target for Humana is $289.05, which is 12.60% higher than the current price. The consensus rating is "Hold".
| Price Target | $289.05 |
| Price Target Difference | 12.60% |
| Analyst Consensus | Hold |
| Analyst Count | 23 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | 36.17% |
Stock ForecastsStock Splits
The last stock split was on August 1, 1991. It was a forward split with a ratio of 1.5:1.
| Last Split Date | Aug 1, 1991 |
| Split Type | Forward |
| Split Ratio | 1.5:1 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 6 |